Lurie Cancer Center Completes Dosing of First Patient with LIXTE’s LB-100 in Combination with GSK’s Immunotherapy Dostarlimab -- PASADENA, CALIF., Feb. 25, 2025 (GLOBE NEWSWIRE) -- LIXTE Biotechnology ...

Lurie Cancer Center initiates trial combining LIXTE's LB-100 and GSK's Dostarlimab for ovarian clear cell cancer treatment. LIXTE Biotechnology Holdings, Inc. has announced that the Robert H.

LIXTE Biotechnology (LIXT) has added the Robert H. Lurie Comprehensive Cancer Center of Northwestern University as a second site in a clinical trial combining the Company’s proprietary compound ...

Following the death of Robert Lurie, Ann Lurie established the Robert H. Lurie cancer center in Chicago. After that, she established the Ann Lurie and Robert H. Lurie children’s hospital.

The foundation supports one Lynn Sage Scholar at the Lurie Cancer Center every year with a $100,000 grant. Kaklamani is using the funds to examine the connection between obesity and breast cancer.

In total, her visit raised nearly $1.5 million for cancer research beneficiaries, including the Robert H. Lurie Comprehensive Cancer Center of Northwestern University. Northwestern President Henry ...

Lurie Comprehensive Cancer Center (Lurie Cancer Center) of Northwestern University as a second site in a clinical trial combining the Company’s proprietary compound LB-100 with GSK’s ...

Lurie Comprehensive Cancer Center (Lurie Cancer Center) of Northwestern University as a second site in a clinical trial combining the Company's proprietary compound LB-100 with GSK's Dostarlimab to ...